Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Benefit of Report Card Feedback After Point-of-Care Assessment of Communication Quality Indicators.

Farrell MH, Sprenger CR, Sullivan SL, Trisler BA, Kram JJF, Ruppel EK.

J Patient Cent Res Rev. 2017 Jan 31;4(1):7-17. doi: 10.17294/2330-0698.1283. eCollection 2017 Winter.

PMID:
31413965
2.

The parietal operculum preferentially encodes heat pain and not salience.

Horing B, Sprenger C, Büchel C.

PLoS Biol. 2019 Aug 12;17(8):e3000205. doi: 10.1371/journal.pbio.3000205. [Epub ahead of print]

3.

How Stereotypes Affect Pain.

Schwarz KA, Sprenger C, Hidalgo P, Pfister R, Diekhof EK, Büchel C.

Sci Rep. 2019 Jun 13;9(1):8626. doi: 10.1038/s41598-019-45044-y.

4.

Hedonic processing in humans is mediated by an opioidergic mechanism in a mesocorticolimbic system.

Buchel C, Miedl S, Sprenger C.

Elife. 2018 Nov 16;7. pii: e39648. doi: 10.7554/eLife.39648.

5.

Classification and characterisation of brain network changes in chronic back pain: A multicenter study.

Mano H, Kotecha G, Leibnitz K, Matsubara T, Sprenger C, Nakae A, Shenker N, Shibata M, Voon V, Yoshida W, Lee M, Yanagida T, Kawato M, Rosa MJ, Seymour B.

Version 2. Wellcome Open Res. 2018 Oct 10 [revised 2018 Jan 1];3:19. doi: 10.12688/wellcomeopenres.14069.2. eCollection 2018.

6.

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.

Sharp A, Coleman I, Yuan W, Sprenger C, Dolling D, Rodrigues DN, Russo JW, Figueiredo I, Bertan C, Seed G, Riisnaes R, Uo T, Neeb A, Welti J, Morrissey C, Carreira S, Luo J, Nelson PS, Balk SP, True LD, de Bono JS, Plymate SR.

J Clin Invest. 2019 Jan 2;129(1):192-208. doi: 10.1172/JCI122819. Epub 2018 Nov 26.

7.

Anterior cingulate cortex connectivity is associated with suppression of behaviour in a rat model of chronic pain.

Morris LS, Sprenger C, Koda K, de la Mora DM, Yamada T, Mano H, Kashiwagi Y, Yoshioka Y, Morioka Y, Seymour B.

Brain Neurosci Adv. 2018 Jun 5;2:2398212818779646. doi: 10.1177/2398212818779646. eCollection 2018.

8.

Evidence for a spinal involvement in temporal pain contrast enhancement.

Sprenger C, Stenmans P, Tinnermann A, Büchel C.

Neuroimage. 2018 Dec;183:788-799. doi: 10.1016/j.neuroimage.2018.09.003. Epub 2018 Sep 4.

PMID:
30189340
9.

Italian consensus conference on guidelines for conservative treatment on lower limb muscle injuries in athlete.

Bisciotti GN, Volpi P, Amato M, Alberti G, Allegra F, Aprato A, Artina M, Auci A, Bait C, Bastieri GM, Balzarini L, Belli A, Bellini G, Bettinsoli P, Bisciotti A, Bisciotti A, Bona S, Brambilla L, Bresciani M, Buffoli M, Calanna F, Canata GL, Cardinali D, Carimati G, Cassaghi G, Cautero E, Cena E, Corradini B, Corsini A, D'Agostino C, De Donato M, Delle Rose G, Di Marzo F, Di Pietto F, Enrica D, Eirale C, Febbrari L, Ferrua P, Foglia A, Galbiati A, Gheza A, Giammattei C, Masia F, Melegati G, Moretti B, Moretti L, Niccolai R, Orgiani A, Orizio C, Pantalone A, Parra F, Patroni P, Pereira Ruiz MT, Perri M, Petrillo S, Pulici L, Quaglia A, Ricciotti L, Rosa F, Sasso N, Sprenger C, Tarantola C, Tenconi FG, Tosi F, Trainini M, Tucciarone A, Yekdah A, Vuckovic Z, Zini R, Chamari K.

BMJ Open Sport Exerc Med. 2018 May 24;4(1):e000323. doi: 10.1136/bmjsem-2017-000323. eCollection 2018.

10.

A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.

Spiegelstein O, Mimrod D, Rabinovich L, Eyal E, Sprenger C, Elgart A, Samara E, Morganroth J.

Clin Pharmacol Drug Dev. 2019 Jan;8(1):49-59. doi: 10.1002/cpdd.442. Epub 2018 May 22.

PMID:
29786964
11.

Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil.

Sprenger C, Eichler IC, Eichler L, Zöllner C, Büchel C.

J Neurosci. 2018 Mar 7;38(10):2454-2470. doi: 10.1523/JNEUROSCI.2496-17.2018. Epub 2018 Feb 12.

12.

The potential of AR-V7 as a therapeutic target.

Uo T, Plymate SR, Sprenger CC.

Expert Opin Ther Targets. 2018 Mar;22(3):201-216. doi: 10.1080/14728222.2018.1439016. Epub 2018 Feb 15. Review.

PMID:
29417861
13.

Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer.

McClinch K, Avelar RA, Callejas D, Izadmehr S, Wiredja D, Perl A, Sangodkar J, Kastrinsky DB, Schlatzer D, Cooper M, Kiselar J, Stachnik A, Yao S, Hoon D, McQuaid D, Zaware N, Gong Y, Brautigan DL, Plymate SR, Sprenger CCT, Oh WK, Levine AC, Kirschenbaum A, Sfakianos JP, Sears R, DiFeo A, Ioannou Y, Ohlmeyer M, Narla G, Galsky MD.

Cancer Res. 2018 Apr 15;78(8):2065-2080. doi: 10.1158/0008-5472.CAN-17-0123. Epub 2018 Jan 22.

14.

Androgen Receptor Variants and Castration-resistant Prostate Cancer: Looking Back and Looking Forward.

Uo T, Sprenger C.

Eur Urol. 2018 May;73(5):724-726. doi: 10.1016/j.eururo.2017.12.020. Epub 2018 Jan 3. No abstract available.

PMID:
29306511
15.

Nocebo-induced modulation of cerebral itch processing - An fMRI study.

van de Sand MF, Menz MM, Sprenger C, Büchel C.

Neuroimage. 2018 Feb 1;166:209-218. doi: 10.1016/j.neuroimage.2017.10.056. Epub 2017 Oct 28.

PMID:
29107770
16.

Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia.

Tinnermann A, Geuter S, Sprenger C, Finsterbusch J, Büchel C.

Science. 2017 Oct 6;358(6359):105-108. doi: 10.1126/science.aan1221.

PMID:
28983051
17.

Suppression of Striatal Prediction Errors by the Prefrontal Cortex in Placebo Hypoalgesia.

Schenk LA, Sprenger C, Onat S, Colloca L, Büchel C.

J Neurosci. 2017 Oct 4;37(40):9715-9723. doi: 10.1523/JNEUROSCI.1101-17.2017. Epub 2017 Sep 7.

18.

Allosteric alterations in the androgen receptor and activity in prostate cancer.

Uo T, Plymate SR, Sprenger CC.

Endocr Relat Cancer. 2017 Sep;24(9):R335-R348. doi: 10.1530/ERC-17-0108. Review.

PMID:
28808043
19.

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.

Henzler C, Li Y, Yang R, McBride T, Ho Y, Sprenger C, Liu G, Coleman I, Lakely B, Li R, Ma S, Landman SR, Kumar V, Hwang TH, Raj GV, Higano CS, Morrissey C, Nelson PS, Plymate SR, Dehm SM.

Nat Commun. 2016 Nov 29;7:13668. doi: 10.1038/ncomms13668.

20.

Endogenous Testosterone and Exogenous Oxytocin Modulate Attentional Processing of Infant Faces.

Holtfrerich SK, Schwarz KA, Sprenger C, Reimers L, Diekhof EK.

PLoS One. 2016 Nov 18;11(11):e0166617. doi: 10.1371/journal.pone.0166617. eCollection 2016.

21.

Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.

Uo T, Dvinge H, Sprenger CC, Bradley RK, Nelson PS, Plymate SR.

Oncogene. 2017 Mar;36(10):1440-1450. doi: 10.1038/onc.2016.313. Epub 2016 Oct 3.

22.

Comparing Painful Stimulation vs Rest in Studies of Pain.

Büchel C, Geuter S, Sprenger C.

JAMA Neurol. 2016 Oct 1;73(10):1258-1259. doi: 10.1001/jamaneurol.2016.2989. No abstract available.

PMID:
27571163
23.

Physiological brainstem mechanisms of trigeminal nociception: An fMRI study at 3T.

Schulte LH, Sprenger C, May A.

Neuroimage. 2016 Jan 1;124(Pt A):518-525. doi: 10.1016/j.neuroimage.2015.09.023. Epub 2015 Sep 21.

PMID:
26388554
24.

Are Children the Better Placebo Analgesia Responders? An Experimental Approach.

Wrobel N, Fadai T, Sprenger C, Hebebrand J, Wiech K, Bingel U.

J Pain. 2015 Oct;16(10):1005-11. doi: 10.1016/j.jpain.2015.06.013. Epub 2015 Jul 26.

PMID:
26220308
25.

Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: a coming of age for AR splice variants?

Sprenger C, Uo T, Plymate S.

Ann Oncol. 2015 Sep;26(9):1805-7. doi: 10.1093/annonc/mdv311. Epub 2015 Jul 21. No abstract available.

26.

Virus removal vs. subsurface water velocity during slow sand filtration.

Dizer H, Brackmann B, Rahman MA, Szewzyk R, Sprenger C, Holzbecher E, López-Pila JM.

J Water Health. 2015 Jun;13(2):371-82. doi: 10.2166/wh.2014.086.

PMID:
26042970
27.

Spinal cord-midbrain functional connectivity is related to perceived pain intensity: a combined spino-cortical FMRI study.

Sprenger C, Finsterbusch J, Büchel C.

J Neurosci. 2015 Mar 11;35(10):4248-57. doi: 10.1523/JNEUROSCI.4897-14.2015.

28.

Extended-duration dosing and distribution of dalbavancin into bone and articular tissue.

Dunne MW, Puttagunta S, Sprenger CR, Rubino C, Van Wart S, Baldassarre J.

Antimicrob Agents Chemother. 2015 Apr;59(4):1849-55. doi: 10.1128/AAC.04550-14. Epub 2015 Jan 5.

29.

BOLD responses to itch in the human spinal cord.

van de Sand MF, Sprenger C, Büchel C.

Neuroimage. 2015 Mar;108:138-43. doi: 10.1016/j.neuroimage.2014.12.019. Epub 2014 Dec 12.

PMID:
25497685
30.

MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.

Liu G, Sprenger C, Wu PJ, Sun S, Uo T, Haugk K, Epilepsia KS, Plymate S.

Oncotarget. 2015 Jan 1;6(1):288-304.

31.

Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape.

Long TJ, Sprenger CC, Plymate SR, Ratner BD.

Biomaterials. 2014 Sep;35(28):8164-74. doi: 10.1016/j.biomaterials.2014.04.090. Epub 2014 Jun 15.

32.

Removal of indigenous coliphages and enteric viruses during riverbank filtration from highly polluted river water in Delhi (India).

Sprenger C, Lorenzen G, Grunert A, Ronghang M, Dizer H, Selinka HC, Girones R, Lopez-Pila JM, Mittal AK, Szewzyk R.

J Water Health. 2014 Jun;12(2):332-42. doi: 10.2166/wh.2014.134.

PMID:
24937227
33.

The link between androgen receptor splice variants and castration-resistant prostate cancer.

Sprenger CC, Plymate SR.

Horm Cancer. 2014 Aug;5(4):207-17. doi: 10.1007/s12672-014-0177-y. Epub 2014 May 6. Review.

34.

Placebo analgesia: a predictive coding perspective.

Büchel C, Geuter S, Sprenger C, Eippert F.

Neuron. 2014 Mar 19;81(6):1223-1239. doi: 10.1016/j.neuron.2014.02.042. Review.

35.

Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinson's disease: a thorough QT/QTc study.

Mendzelevski B, Sprenger CR, Spiegelstein O, Rabinovich-Guilatt L.

Int J Clin Pharmacol Ther. 2014 Mar;52(3):192-201. doi: 10.5414/CP201955.

PMID:
24447649
36.

Effect of oxytocin on placebo analgesia: a randomized study.

Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U.

JAMA. 2013 Oct 23;310(16):1733-5. doi: 10.1001/jama.2013.277446. No abstract available.

PMID:
24150470
37.

Age-dependent decline of endogenous pain control: exploring the effect of expectation and depression.

Grashorn W, Sprenger C, Forkmann K, Wrobel N, Bingel U.

PLoS One. 2013 Sep 27;8(9):e75629. doi: 10.1371/journal.pone.0075629. eCollection 2013.

38.

Expectation requires treatment to boost pain relief: an fMRI study.

Schenk LA, Sprenger C, Geuter S, Büchel C.

Pain. 2014 Jan;155(1):150-7. doi: 10.1016/j.pain.2013.09.024. Epub 2013 Sep 26.

PMID:
24076046
39.

AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer.

Liu G, Sprenger C, Sun S, Epilepsia KS, Haugk K, Zhang X, Coleman I, Nelson PS, Plymate S.

Neoplasia. 2013 Sep;15(9):1009-17.

40.

Combined T2*-weighted measurements of the human brain and cervical spinal cord with a dynamic shim update.

Finsterbusch J, Sprenger C, Büchel C.

Neuroimage. 2013 Oct 1;79:153-61. doi: 10.1016/j.neuroimage.2013.04.021. Epub 2013 Apr 17.

PMID:
23603283
41.

Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo.

Carr DB, McDonnell Moorehead T, Bouchard A, Sprenger CR, Hamilton DA, Lang E, Madden D, Lacouture PG, Wright C 4th.

Clin Ther. 2013 May;35(5):646-58. doi: 10.1016/j.clinthera.2013.03.014. Epub 2013 Apr 8.

42.

Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.

Dean JP, Sprenger CC, Wan J, Haugk K, Ellis WJ, Lin DW, Corman JM, Dalkin BL, Mostaghel E, Nelson PS, Cohen P, Montgomery B, Plymate SR.

J Clin Endocrinol Metab. 2013 May;98(5):E820-8. doi: 10.1210/jc.2012-3856. Epub 2013 Mar 26.

43.

Capillary force seeding of sphere-templated hydrogels for tissue-engineered prostate cancer xenografts.

Long TJ, Takeno M, Sprenger CC, Plymate SR, Ratner BD.

Tissue Eng Part C Methods. 2013 Sep;19(9):738-44. doi: 10.1089/ten.TEC.2012.0388. Epub 2013 Mar 18.

44.

White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia.

Stein N, Sprenger C, Scholz J, Wiech K, Bingel U.

Pain. 2012 Nov;153(11):2210-7. doi: 10.1016/j.pain.2012.07.010. Epub 2012 Sep 5.

PMID:
22959599
45.

Attention modulates spinal cord responses to pain.

Sprenger C, Eippert F, Finsterbusch J, Bingel U, Rose M, Büchel C.

Curr Biol. 2012 Jun 5;22(11):1019-22. doi: 10.1016/j.cub.2012.04.006. Epub 2012 May 17.

46.

Time discounting predicts creditworthiness.

Meier S, Sprenger CD.

Psychol Sci. 2012 Jan 1;23(1):56-8. doi: 10.1177/0956797611425931. Epub 2011 Dec 7. No abstract available.

PMID:
22157518
47.

Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.

Sprenger CC, Plymate SR, Reed MJ.

Int J Cancer. 2010 Dec 15;127(12):2739-48. doi: 10.1002/ijc.25615. Epub 2010 Oct 8. Review.

48.

Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation.

Sprenger C, Bingel U, Büchel C.

Pain. 2011 Feb;152(2):428-39. doi: 10.1016/j.pain.2010.11.018. Epub 2010 Dec 31.

PMID:
21196078
49.

Vulnerability of bank filtration systems to climate change.

Sprenger C, Lorenzen G, Hülshoff I, Grützmacher G, Ronghang M, Pekdeger A.

Sci Total Environ. 2011 Jan 15;409(4):655-63. doi: 10.1016/j.scitotenv.2010.11.002. Epub 2010 Nov 26. Review.

PMID:
21112614
50.

A simple method to hide data loggers safely in observation wells.

Lorenzen G, Sprenger C, Pekdeger A.

Ground Water. 2011 May-Jun;49(3):450-3. doi: 10.1111/j.1745-6584.2010.00771.x. Epub 2010 Nov 18.

PMID:
21087249

Supplemental Content

Loading ...
Support Center